Please login to the form below
GAVI Alliance
This page shows the latest GAVI Alliance news and features for those working in and with pharma, biotech and healthcare.
First shipments of AZ/Oxford COVID-19 vaccine sent through COVAX
countries. In June 2020, AZ signed agreements with the Coalition for Epidemic Preparedness Innovation (CEPI), Gavi the Vaccine Alliance and SII. ... COVAX is the vaccine pillar of the World Health Organization's (WHO) ACT Accelerator – a collaborative
Latest news
-
EU set to contribute €1bn to COVAX
COVAX is the vaccine pillar of the World Health Organization's (WHO) ACT Accelerator – a collaborative initiative co-led by the WHO, Gavi, the Vaccine Alliance and the Coalition for Epidemic
-
Novavax to provide 1.1 billion COVID-19 vaccine doses to COVAX
Memorandum of understanding announced between Novavax, Gavi and the Vaccine Alliance. ... The memorandum of understanding between Gavi, the Vaccine Alliance and Novavax for the vaccine doses was announced yesterday.
-
CEPI establishes global network to compare COVID-19 vaccines
CEPI, along with the World Health Organization and the Gavi vaccines alliance, is co-leading the COVAX facility – an initiative aiming to ensure equitable access to COVID-19 vaccines.
-
Gavi says 76 wealthy countries have committed to COVAX vaccine facility
Countries have signed intent to joining COVID-19 vaccine initiative. Gavi vaccines alliance’s chief executive Seth Berkley has revealed that 76 high-income countries have now committed to joining the
-
EU to contribute €400m to WHO’s COVID-19 vaccine facility
The COVAX facility is co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO.
EU set to contribute €1bn to COVAX
Novavax to provide 1.1 billion COVID-19 vaccine doses to COVAX
EU to contribute €400m to WHO’s COVID-19 vaccine facility
More from news
Approximately 3 fully matching, plus 25 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
At the end of April, Gavi, the Vaccine Alliance, was already reporting vaccine shortages in at least 21 LMICs.
-
ASEAN: Domestic vaccines manufacturers
Since its foundation in 2000, the Global Alliance for Vaccines and Immunisation (GAVI) has facilitated the introduction of essential vaccines throughout the least developed countries, such as pentavalent vaccine ... GAVI has not limited itself by handing
How will COVID-19 affect uptake of vaccinations against other diseases?
ASEAN: Domestic vaccines manufacturers
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Is the world ready for a COVID-19 vaccine?
One of the ways the world is looking to mitigate this is through the COVAX initiative, which is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Alliance ... for Vaccines and Immunisation (GAVI) and the WHO.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- New data from Moderna supports COVID boosters
- $47.5m research centre to seek genetic insights into disease
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- David Hunt launches independent agency The Considered
- bluebird bio gears up for split
- Ashfield Health announces three new senior hires
- The new reality of building a corporate brand in pharma
- EU “still interested” in Valneva COVID vaccine despite UK snub
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
